与制造母乳替代品的公司合作:EAACI的立场论文
Stefania Arasi1, Jean-Christoph Caubet2, Ozlem Ceylan3
1Allergy Diseases Research Area, Pediatric Allergology Unit, Bambino Gesù Children's Hospital IRCCS, Rome, Italy.
概括
母乳最适合婴儿,但可能需要母乳替代品 (BMS). 医疗保健专业人员需要指导来推安全的BMS替代品,确保科学和健康动机指导决策.
科学领域:
- 儿科 儿科 儿科
- 营养科学 营养科学
- 公共卫生 公共卫生
背景情况:
- 母乳是婴儿最初6个月至2岁的最佳营养来源,补充食物.
- 母乳替代品 (BMS) 可能是必要的,因为母亲/孩子的条件或个人选择.
- 医疗保健专业人员 (HCP) 需要明确的指导方针,在需要时推BMS.
研究的目的:
- 为欧洲过敏和临床免疫学会 (EAACI) 提供关于与BMS制造商互动的建议.
- 为EAACI与BMS行业的接触建立监督协议.
- 确保医疗保健工作人员有能力根据科学和健康原则推合适的BMS.
主要方法:
- 制定EAACI工作组"奶粉配方产业赞助"的建议.
- 专注于定义EAACI和BMS生产商之间的适当互动和监督机制.
- 根据科学证据和婴儿健康考虑制定指导方针.
主要成果:
- 为EAACI与BMS制造商的接触制定了明确的建议.
- 概述了监督这些互动的框架.
- 在BMS建议中强调科学和健康驱动的决策的重要性.
结论:
- 亚航国际航空公司已经制定了与BMS制造商管理关系的指导方针.
- 这些建议旨在确保BMS的任何使用都基于必要性,并以专家知识为指导.
- 对行业互动的监督对于保持信任和优先考虑婴儿健康至关重要.
相关概念视频
Pharmaceutical Alternatives: Excipients and Impurities-Related Therapeutic Nonequivalence
242
Pharmaceutical products contain more than just the active drug; they also contain various excipients such as binders, solubilizers, stabilizers, preservatives, and other elements. In some cases, impurities or contaminants might be present. Traditionally, quality control in pharmaceuticals has primarily focused on the analysis of the active drug, often overlooking the impact of these additional components. The recent issue with heparin contamination by over-sulfated chondroitin sulfate, a...
242
Production of Pharmaceuticals
99
Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under...
99


